Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 5, Pages 2570-2579
Publisher
American Society for Microbiology
Online
2014-02-19
DOI
10.1128/aac.01705-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population Pharmacokinetics of Colistin Methanesulfonate in Rats: Achieving Sustained Lung Concentrations of Colistin for Targeting Respiratory Infections
- (2013) Shalini W. S. Yapa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of four different brands of colistimethate and formed colistin in rats
- (2013) H. He et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients
- (2012) Zoe E. Athanassa et al. INTENSIVE CARE MEDICINE
- Recent advances in the treatment of Pseudomonas aeruginosainfections in cystic fibrosis
- (2011) Niels Høiby BMC Medicine
- Pharmacokinetics of Colistin and Colistimethate Sodium After a Single 80-mg Intravenous Dose of CMS in Young Healthy Volunteers
- (2011) W Couet et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)
- (2011) A. C. Gales et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Aerosol Therapy with Colistin Methanesulfonate: a Biopharmaceutical Issue Illustrated in Rats
- (2010) S. Marchand et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
- (2010) Roberto Imberti et al. CHEST
- Pseudomonas aeruginosabiofilms in cystic fibrosis
- (2010) Niels Høiby et al. Future Microbiology
- Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients
- (2010) Gerd Döring INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Evaluating the stability of colistin and colistin methanesulphonate in human plasma under different conditions of storage
- (2010) R. V. Dudhani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
- (2009) Joshua D. Hartzell et al. CLINICAL INFECTIOUS DISEASES
- Colistin in the 21st century
- (2009) Roger L Nation et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients
- (2008) S. J. Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience
- (2008) C.R. Hansen et al. Journal of Cystic Fibrosis
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now